Details for Patent: 9,770,570
✉ Email this page to a colleague
Which drugs does patent 9,770,570 protect, and when does it expire?
Patent 9,770,570 protects INOMAX and is included in one NDA.
Protection for INOMAX has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has thirty-eight patent family members in twelve countries.
Summary for Patent: 9,770,570
| Title: | Apparatus and method for monitoring nitric oxide delivery |
| Abstract: | Described is an apparatus for monitoring nitric oxide delivery, wherein such apparatus comprises an indicator to inform a user of the apparatus when the flow of breathing gas rises above or falls below a predetermined level or range. Also described is a method of monitoring nitric oxide delivery, wherein the flow of breathing gas is measured and displayed. In some embodiments, an alert is provided when the flow of breathing gas rises above or falls below a predetermined level or range. |
| Inventor(s): | Schnitman; Robert (Colchester, CT), Medicis; Joseph J. (Syracuse, NY), Potenziano; Jim (Binghamton, NY), Acker; Jaron (Madison, WI), Schmidt; Jeffrey (Oregon, WI) |
| Assignee: | Mallinckrodt Hospital Products IP Limited (Dublin, IE) |
| Application Number: | 13/671,057 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,770,570 |
|
Patent Claim Types: see list of patent claims | Use; Delivery; Device; |
Drugs Protected by US Patent 9,770,570
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mallinckrodt Hosp | INOMAX | nitric oxide | GAS;INHALATION | 020845-003 | Dec 23, 1999 | AA | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,770,570
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2012335937 | ⤷ Try a Trial | |||
| Australia | 2014244334 | ⤷ Try a Trial | |||
| Australia | 2018204804 | ⤷ Try a Trial | |||
| Australia | 2020202541 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
